REQUEST A DEMO
Total
USD $0.00
Search more companies

Mystipharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Drinking Places (Alcoholic Beverages)
Full name: Mystipharma Sp. z o.o. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Mystipharma Sp. z o.o. is an enterprise located in Poland, with the main office in Lublin. The enterprise operates in the Department Stores industry. It was first established on February 18, 2022. The company’s latest financial report indicates a net sales revenue drop of 88.62% in 2024. Its’ total assets recorded a negative growth of 37.17%.

Headquarters
Ul. Gospodarcza 26
Lublin; Lubelskie; Postal Code: 20-213

Contact Details: Purchase the Mystipharma Sp. z o.o. report to view the information.

Website: http://www.mystipharma.com

Basic Information
Registered Capital:
Purchase the Mystipharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Mystipharma Sp. z o.o. report to view the information.
Incorporation Date:
February 18, 2022
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Mystipharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-88.62%
Total operating revenue
-89.08%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-37.17%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
216.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?